Advanced search
Publication Cover
Leukemia & Lymphoma Volume 42, 2001 - Issue 6
Submit an article Journal homepage
92
Views
13
CrossRef citations to date
0
Altmetric
Original Article

CD40 Ligand Immunotherapy in Cancer: An Efficient Approach

Naruo Kuwashima Department of Surgery, Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokya, 105-8461, Japan
,
Shigeru Kageyama Division of Pharmacology and Therapeutics, Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokya, 105-8461, Japan
,
Yoshikatsu Eto Department of Pediatrics, Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokya, 105-8461, Japan
&
Mitsuyoshi Urashima Division of Pharmacology and Therapeutics, Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokya, 105-8461, Japan; Division of Pharmacology and Therapeutics, Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokya, 105-8461, Japan; Department of Pediatrics, Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokya, 105-8461, Japan
Pages 1367-1377 | Published online: 01 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Daisuke Ito, Aric M. Frantz, Christina Williams, Rachael Thomas, Robert C. Burnett, Anne C. Avery, Matthew Breen, Nicola J. Mason, Timothy D. O’Brien & Jaime F. Modiano. (2012) CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies. Leukemia & Lymphoma 53:7, pages 1390-1398.
Read now

Articles from other publishers (12)

Taha Elmetwali, Asmaa Salman, Wenbin Wei, Syed A. Hussain, Lawrence S. Young & Daniel H. Palmer. (2020) CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation. Scientific Reports 10:1.
Crossref
Li-ping Pang, Wei Huang, Qi Sun, Wei Guo, Run-tao Li & Jing-rong Cui. (2008) SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells. Anti-Cancer Drugs 19:2, pages 167-174.
Crossref
Renier J. Brentjens. (2006) Novel approaches to the immunotherapy of B-cell malignancies: An update. Current Hematologic Malignancy Reports 1:4, pages 258-263.
Crossref
Angelica Loskog, Christina Ninalga & Thomas H. Tötterman. (2005) Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors. Cancer Immunology, Immunotherapy 55:5, pages 588-597.
Crossref
Mitsuyoshi Urashima, Mio Sakuma, Satoshi Teramoto, Yuichi Fuyama, Yoshikatsu Eto, Kazuhiro Kondo & Tadao Tanaka. (2005) Gene Expression Profiles of Peripheral and Cord Blood Mononuclear Cells Altered by Thymic Stromal Lymphopoietin. Pediatric Research 57:4, pages 563-569.
Crossref
Amy CostelloChristine Rey-HipolitoAneeta PatelKevin OakleyVasyl VascoChris CalabriaR. Michael TuttleGary L. Francis. (2005) Thyroid Cancers Express CD-40 and CD-40 Ligand: Cancers That Express CD-40 Ligand May Have a Greater Risk of Recurrence in Young Patients. Thyroid 15:2, pages 105-113.
Crossref
Renier J. Brentjens. (2004) Novel approaches to immunotherapy for B-cell malignancies. Current Oncology Reports 6:5, pages 339-347.
Crossref
Giovanna D'AmicoMarisa VulcanoCristina BugarinGiancarlo BianchiGisella PirovanoMartin BonaminoVirna MarinPaola AllavenaEttore BiagiAndrea Biondi. (2004) CD40 activation of BCP-ALL cells generates IL-10–producing, IL-12–defective APCs that induce allogeneic T-cell anergy. Blood 104:3, pages 744-751.
Crossref
Dimitris Daoussis, Andrew P. Andonopoulos & Stamatis-Nick C. Liossis. (2004) Targeting CD40L: a Promising Therapeutic Approach. Clinical and Vaccine Immunology 11:4, pages 635-641.
Crossref
M Bonamino, M Serafini, G D'Amico, G Gaipa, E Todisco, S Bernasconi, J Golay, A Biondi & M Introna. (2003) Functional transfer of CD40L gene in human B-cell precursor ALL blasts by second-generation SIN lentivectors. Gene Therapy 11:1, pages 85-93.
Crossref
Renier J. Brentjens & Michel Sadelain. 2004. Treatment of Leukemia and Lymphoma. Treatment of Leukemia and Lymphoma 347 370 .
Yosuke Kawakami, Tyler J Curiel & David T Curiel. 2003. 327 337 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.